Open-loop dynamic and static characteristics of the carotid sinus baroreflex in rats with chronic heart failure after

Toru Kawada1, Meihua Li, Atsunori Kamiya

  • 1Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka, 565-8565, Japan. torukawa@res.ncvc.go.jp

Insights

Chronic heart failure (CHF) impairs the baroreflex

Area of Science:

  • Cardiovascular Physiology
  • Autonomic Nervous System Regulation
  • Heart Failure Pathophysiology

Background:

  • The carotid sinus baroreflex is crucial for maintaining arterial pressure homeostasis.
  • Chronic heart failure (CHF) is associated with autonomic dysfunction.
  • Dynamic baroreflex function in CHF requires further elucidation.

Purpose of the Study:

  • To estimate the open-loop dynamic characteristics of the carotid sinus baroreflex in rats with CHF.
  • To compare neural and peripheral arc dynamics between normal control and CHF rats.
  • To assess the impact of CHF on arterial pressure buffering capacity.

Main Methods:

  • Assessment of neural arc transfer function (carotid sinus pressure to splanchnic sympathetic nerve activity).
  • Assessment of peripheral arc transfer function (splanchnic sympathetic nerve activity to arterial pressure).
  • Simulation study to evaluate arterial pressure recovery and buffering reserve.

Main Results:

  • Neural arc steady-state response was attenuated in CHF, but dynamic characteristics were preserved.
  • Peripheral arc steady-state response and initial slope were reduced in CHF, indicating impaired end-organ responses.
  • CHF rats showed a reduced arterial pressure recovery and buffering reserve, especially with larger disturbances.

Conclusions:

  • The neural component of the baroreflex is relatively preserved in CHF.
  • The peripheral component and end-organ responsiveness are impaired in CHF.
  • CHF leads to a loss of arterial pressure buffering capacity despite maintained baseline arterial pressure.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...